NDEWS Presents are monthly webinars convened by the NDEWS Coordinating Center to explore emerging drugs and timely drug-related topics. Future webinars will offer in-depth reviews of newly detected drugs, timely drug issues or trends, and events in specific geographical areas. Webinars may also be convened to explore innovative research and resources for better understanding changes in drug use and drug use trends in the United States.

Timely Topics are a series of short videos (approx 5 min - 30 min) that cover current issues of interest.

Timely Topics

• Synthetic Drug Threats in the United States: 2020 Update (3/25/2020) Run time: 10:46
  Emily D. Lockhart, DEA
• The Current State: Vaping, Devices, and E-liquids (10/7/2019) Run time: 31:21
  Dr. Michelle Peace
  • Discuss this video with Dr. Michelle Peace on the NDEWS Network
     

2020 Webinars

• Remembrance of Things Passed: Using Urinalysis Results to Monitor Emerging Drug Use, DUF to EDDS (7/28/2020)
  Eric D. Wish, PhD
• Statewide Assessment of Drug Use and Services in Maryland: Results from a 2019 Study (7/15/2020) [In production]
  Andrea M. López, Ph.D. and Danielle German, Ph.D., MPH
• Substance Use and Responses During COVID-19: New York City Department of Health and Mental Hygiene (5/18/2020)
  Denise Paone, EdD and Michelle Nolan, MPH
  [Data reviewed in this webinar was pulled 5/17/2020 at 1:45pm]

2019 Webinars

• Perspectives on Cases of E-Cigarette, or Vaping Related Lung Injury from 2 Poison Control Centers (11/26/2019)
  Diane P. Calello, MD and Michael Lynch, MD
  • Webinar Brief: 1-Pager Summary 
• Perceptions of Naloxone Among Urban Opioid Users in 3 Cities (10/29/2019)
  • The three studies: Characterizing Knowledge, Attitudes, Behaviors, and Practices Related to Bystander Naloxon
    Lee Hoffer, Ph.D., Kavita Babu, M.D., and Annabelle Belcher, Ph.D.
• Patterns of Methamphetamine and Opioid Co-Use in Oregon (9/18/2019)
  Andrea M. Lopez, Ph.D. and Eric Geisler M.D.
• Leveraging ODMAP and Collective Partnerships to Address the Overdose Epidemic (6/18/2019)
  Aliese Alter and Lauren Whiteman
• Recent enhancements in the timeliness and specificity of drug overdose death certificate data from NCHS (5/22/2019)
  Margaret Warner, PhD
• Historical and Current Patterns of Cocaine Use in the US and Two NDEWS Sentinel Sites (4/16/2017)
  James N. Hall, Denise Paone, EdD, and Marcella H. Sorg, PhD
• Historical and Current Patterns of Methamphetamine Use in the US and Three NDEWS Sentinel Sites (3/25/2019)
  James N. Hall, Jane C. Maxwell, PhD, Brian J. Dew, PhD, and Mary-Lynn Brecht, PhD
• Drug Threats in the United States: 2019 Update (3/13/2019) 
  Jill M. Head
• Using Science to Shape Drug Policy: Past, Present and Future (2/27/2019)
  Robert L. DuPont, MD
• The Electronic Cigarette Dragon: The Public Health Concern That Became a Criminal Justice Challenge (1/9/2019)
  Michelle R. Peace, Ph.D.

2018 Webinars

• Risk and Resilience in the US ‘Heroin’ Epidemic (11/13/2018)
  Daniel Ciccarone, MD, MPH and Sarah G. Mars, PhD 
• Collecting and Analyzing Cryptomarket Data on Novel Synthetic Opioids (10/24/2018)
  Francois Lamy, Ph.D. and Raminta Daniulaityte, Ph.D. 
• Using the National Hospital Care Survey (NHCS) to Identify Opioid-Related Hospital Visits (6/19/2018)
  Carol DeFrances, Ph.D. and Margaret Noonan, M.A.
• Early Warning at the Global Level: The UNODC Early Warning Advisory on NPS (4/10/18)
  Conor Crean and Martin Raithelhuber
• Gabapentin Diversion and Misuse (3/14/2018)
  Jennifer Havens, Ph.D. and Mance Buttram, Ph.D.
• Synthetic Drug Threats in the United States: 2018 Update (2/28/18)
  Jill M. Head 
• Opioid Commission: A Summary and Lessons Learned (1/10/2018)
  Dr. Bertha K. Madras

2017 Webinars

• Drug Term Discovery Through Social Media Using Natural Language Processing (11/15/2017)
  Dr. Bertha K. Madras and Nikki Adams, Ph.D.
• Understanding the Increase in Opioid Overdoses: NDEWS New Hampshire HotSpot Study Results (9/12/2017)
  Lisa A. Marsch, Ph.D. and Marcella H. Sorg, Ph.D.
• HIDTA’s Overdose Detection Mapping Application Program (ODMAP) and HIDTA Heroin Response Strategy (3/29/2017)
  Jeff Beeson
• Synthetic Drug Threats in the United States: 2017 Update (2/15/2017)
  Jill M. Head

G-DEWS International Series - This is a project to examine existing drug monitoring systems around the world to gain an understanding of how they work, the contexts in which they operate, and to describe areas of best practice. The goal of the project is to develop guidance based on proven practices utilized by existing systems to support countries establishing new drug early warning systems (DEWS).

• Examining Global Drug Early Warning Systems (G-DEWS):
  • Part 1: Monitoring Drug Trends in North America, featuring: NDEWS (U.S.) and CCSA (Canada) (8/30/2017)
    David Newcombe, Ph.D., Erin Artigiani, M.A., Matthew M. Young, Ph.D., and Zachary Patterson, Ph.D.
  • Part 2: Monitoring Drug Trends in Australasia, featuring: NDARC (Australia); and SHORE and CFAR (New Zealand) (9/26/2017)
    Dr. David Newcombe, Dr. Lucinda Burns, and Dr. Christopher Wilkins
  • Part 3: Monitoring Drug Trends in Africa, featuring: SAMRC (South Africa), NACADA (Kenya) and UNODC (Nigeria) (10/3/2017)
    David Newcombe, Ph.D., Nadine Harker Burnhams, Ph.D., Ms. Harsheth Kaur Virk, Ibanga Akanidomo, Ph.D. M.Sc., B.Sc., and Mr. Franklin Mwirichia, MPH
  • Part 4: Monitoring Drug Trends in Europe, featuring: EMCDDA (11/29/2017)
    Rachel Christie, Ph.D.

2016 Webinars

• Using Wastewater Testing as a Drug Epidemiology Tool (11/16/2016)
  Caleb Banta-Green, MSW, MPH, PhD and Daniel Burgard, PhD
• Regional Differences in Opioid and Methamphetamine Trends Across the U.S: Findings from NDEWS Sentinel Community Sites (9/29/16)
  Marcella H. Sorg, Ph.D., James N. Hall, Jane C. Maxwell, Ph.D., and Phillip Coffin, MD, MIA
• Synthetic Opioids in Counterfeit Pharmaceuticals and Other Illicit Street Drugs: The Situation in Canada (7/20/16)
  Matthew M. Young, PhD, Jane A. Buxton, MBBS, MHSc, FRCPC, and Michelle Craig, MSLP
• An Overview of the National Poison Data System and Drug-Related Human Exposure Cases (5/25/16)
  Ashlea A. Zimmerman, MPH
• Designer Drugs of Abuse: The Science Behind  the Headlines (4/27/16)
  Michael Baumann, Ph.D.
• Understanding the Relationship Between Prescription Opioid Misuse and Heroin Abuse (3/28/16)
  Wilson M. Compton, M.D., M.P.E. and Daniel Ciccarone, M.D., MPH
• Synthetic Drug Threats in the United States (2/24/16)
  Jill M. Head

Upcoming Webinars